InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION
Loading...
  • Acciones
  • /
  • Farmacéutica y Biotecnología
Actualizado hace 1d
TSND logo

TerrAscend Corp.Informe acción TSX:TSND

Capitalización bursátil CA$350.3m
Actualizado hace 1d
Precio de las acciones
n/a
1Y-18.3%
7D3.3%
1D0%
Valor de la cartera
​
Ver

TerrAscend Corp.

Informe acción TSX:TSND

Capitalización de mercado: CA$350.3m

  • Resumen empresa
  • Valoración
  • Crecimiento Futuro
  • Rendimiento pasado
  • Salud Financiera
  • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

TerrAscend (TSND) Resumen de Acciones

TerrAscend Corp. cultiva, produce y vende productos de cannabis en Canadá y Estados Unidos. Saber más

Análisis fundamental de TSND
Puntuación del snowflake
Valoración5/6
Crecimiento futuro4/6
Rendimiento pasado0/6
Salud financiera3/6
Dividendos0/6

Recompensas

Cotiza un 59.9% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 105.4%

Cotiza a buen valor en comparación con empresas similares e industria

Análisis de riesgos

No se han detectado riesgos en TSND a partir de nuestros controles de riesgos.

TSND Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
49.9% infravalorado descuento intrínseco
AnalystConsensusTarget
•1y ago

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

37
0
1
AN
AnalystHighTarget
58.2% infravalorado descuento intrínseco
AnalystHighTarget
•1mo ago

US Cannabis Legalization And Digital Health Will Unlock Opportunities

72
0
1
AN
AnalystLowTarget
37.5% infravalorado descuento intrínseco
AnalystLowTarget
•2mo ago

North American Cannabis Will Face Oversupply And Risks Yet Recover

22
0
1

Top Analyst Narratives

AN
AnalystConsensusTarget
49.9% infravalorado descuento intrínseco
AnalystConsensusTarget
•1y ago

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

37
0
1
AN
AnalystHighTarget
58.2% infravalorado descuento intrínseco
AnalystHighTarget
•1mo ago

US Cannabis Legalization And Digital Health Will Unlock Opportunities

72
0
1
AN
AnalystLowTarget
37.5% infravalorado descuento intrínseco
AnalystLowTarget
•2mo ago

North American Cannabis Will Face Oversupply And Risks Yet Recover

22
0
1
View all narratives

Competidores de TerrAscend Corp.

Aurora Cannabis

Symbol: TSX:ACB
Market cap: CA$345.7m

Cresco Labs

Symbol: CNSX:CL
Market cap: CA$482.6m

High Tide

Symbol: TSXV:HITI
Market cap: CA$326.0m

Canopy Growth

Symbol: TSX:WEED
Market cap: CA$571.1m

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del TerrAscend
Precios históricos de las acciones
Precio actual de la acciónCA$0.94
Máximo en las últimas 52 semanasCA$2.00
Mínimo de 52 semanasCA$0.53
Beta2.09
Cambio en 1 mes28.77%
Variación en 3 meses-2.08%
Cambio de 1 año-18.26%
Variación en 3 años-67.36%
Variación en 5 años-89.70%
Variación desde la OPV-22.31%

Noticias y actualizaciones recientes

User avatar
Actualización de narrativa • Aug 10

TSND: Disciplined M&A And Capital Moves Will Support Future Upside

Analysts have adjusted their fair value estimate for TerrAscend to CA$2.25 from CA$2.01 as they revisit assumptions on revenue growth, profit margins and future P/E expectations. What's in the News for TerrAscend TerrAscend executives reiterated on the second quarter 2026 results call that the company is seeking acquisitions that are accretive and focused on markets where it already has scale and infrastructure, with an emphasis on using existing operations to pursue higher vertical revenue and operating leverage.
User avatar
Actualización de narrativa • Jul 02

TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside

Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.

Recent updates

User avatar
Actualización de narrativa • Aug 10

TSND: Disciplined M&A And Capital Moves Will Support Future Upside

Analysts have adjusted their fair value estimate for TerrAscend to CA$2.25 from CA$2.01 as they revisit assumptions on revenue growth, profit margins and future P/E expectations. What's in the News for TerrAscend TerrAscend executives reiterated on the second quarter 2026 results call that the company is seeking acquisitions that are accretive and focused on markets where it already has scale and infrastructure, with an emphasis on using existing operations to pursue higher vertical revenue and operating leverage.
User avatar
Actualización de narrativa • Jul 02

TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside

Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.
User avatar
Actualización de narrativa • Jun 18

TSND: Expanding M&A Pipeline And New Leadership Will Support Future Profitability

Analysts have nudged their fair value price target for TerrAscend to CA$2.01. This reflects updated assumptions for discount rate, revenue growth, profit margin and future P/E that slightly adjust how they frame the stock’s risk and earnings potential.
User avatar
Actualización de narrativa • Jun 03

TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability

Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.
User avatar
Actualización de narrativa • May 07

TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability

Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).
User avatar
Actualización de narrativa • Apr 18

TSND: New CFO Hire And Share Buyback Will Support Future Upside

Analysts have modestly adjusted their price target on TerrAscend, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Together, these factors refine their view of what the shares could be worth in CA$ terms.
User avatar
Actualización de narrativa • Apr 04

TSND: New Brand Partnership And Share Buyback Will Support Future Upside

Analysts have nudged their TerrAscend price target modestly higher to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland, covering premium flower and high potency vape products under its exclusive partnership with the brand (Key Developments).
User avatar
Actualización de narrativa • Mar 20

TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability

Analysts have slightly adjusted their CA$ price target on TerrAscend, citing updated assumptions for revenue growth, profit margins, and a modest change in the expected future P/E multiple. What's in the News TerrAscend completed a share buyback tranche between October 1, 2025 and December 31, 2025, repurchasing 75,000 shares for $0.03m, equal to 0.02% of shares under the program first announced on August 20, 2025 (Key Developments).
User avatar
Actualización de narrativa • Mar 04

TSND: Expanded New Jersey Footprint Will Support Future Profitability

Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from about CA$1.98, citing updated assumptions that include a modestly adjusted discount rate, changes to revenue growth and profit margin expectations, and a higher future P/E estimate. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey.
User avatar
Actualización de narrativa • Feb 18

TSND: Union Chill Expansion Will Support Future Retail Scale And Margins

Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).
Artículo de análisis • Feb 12

More Unpleasant Surprises Could Be In Store For TerrAscend Corp.'s (TSE:TSND) Shares After Tumbling 27%

TerrAscend Corp. ( TSE:TSND ) shares have had a horrible month, losing 27% after a relatively good period beforehand...
User avatar
Actualización de narrativa • Feb 04

TSND: Union Chill Deal Will Drive Future Retail And Margin Upside

Analysts have trimmed their price target on TerrAscend to about US$1.25 from roughly US$1.50, citing reduced revenue growth expectations and a lower future P/E multiple, partly offset by higher projected profit margins. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County, New Jersey, and bringing its retail footprint in the state to four dispensaries (Key Developments).
User avatar
Actualización de narrativa • Jan 21

TSND: Expanded Retail Footprint And Licensing Will Support Future Profitability

Analysts have modestly revised their price target on TerrAscend, citing slightly firmer profit margin expectations and a small adjustment to revenue trends and future P/E assumptions. Together, these factors support a refined fair value estimate without a material change in the overall valuation level.
User avatar
Actualización de narrativa • Jan 06

TSND: Expanded Mid Atlantic Footprint And Licensing Will Support Higher Profitability

Analysts have nudged their price target on TerrAscend toward about $2.00, reflecting updated views that incorporate higher projected profit margins, a lower assumed future P/E multiple near 43, and adjusted revenue expectations. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County and bringing TerrAscend's New Jersey retail footprint to four dispensaries (Key Developments).
User avatar
Actualización de narrativa • Dec 15

TSND: Licensing Expansion Into Mid Atlantic Markets Will Drive Stronger Profitability

Analysts have raised their price target on TerrAscend by approximately $2.25 to about $1.98 per share. They cited expectations for stronger profit margins and a more reasonable future earnings multiple, even as they moderate revenue growth assumptions and apply a slightly higher discount rate.
Artículo de análisis • Dec 14

TerrAscend Corp.'s (TSE:TSND) Shares Climb 123% But Its Business Is Yet to Catch Up

TerrAscend Corp. ( TSE:TSND ) shares have had a really impressive month, gaining 123% after a shaky period beforehand...
Artículo de análisis • Nov 09

Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75

TerrAscend Corp. ( TSE:TSND ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...
Artículo de análisis • Oct 30

TerrAscend Corp.'s (TSE:TSND) 27% Share Price Plunge Could Signal Some Risk

The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 27% over the previous 30 days, handing back...
Artículo de análisis • Jun 11

Some TerrAscend Corp. (TSE:TSND) Shareholders Look For Exit As Shares Take 34% Pounding

Unfortunately for some shareholders, the TerrAscend Corp. ( TSE:TSND ) share price has dived 34% in the last thirty...
Artículo de análisis • Apr 27

TerrAscend Corp. (TSE:TSND) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely

The TerrAscend Corp. ( TSE:TSND ) share price has fared very poorly over the last month, falling by a substantial 30...
User avatar
Nueva narrativa • Apr 02

ERP Implementation And Ohio Expansion Will Improve Operational Efficiency

Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration.
Artículo de análisis • Mar 05

With A 29% Price Drop For TerrAscend Corp. (TSE:TSND) You'll Still Get What You Pay For

To the annoyance of some shareholders, TerrAscend Corp. ( TSE:TSND ) shares are down a considerable 29% in the last...
Artículo de análisis • Jan 03

These 4 Measures Indicate That TerrAscend (TSE:TSND) Is Using Debt Extensively

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Artículo de análisis • Sep 03

Is TerrAscend (TSE:TSND) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis • Apr 25

TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Artículo de análisis • Mar 10

What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash

The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 25% over the previous 30 days, handing back...
Artículo de análisis • Jan 24

Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%

TerrAscend Corp. ( TSE:TSND ) shareholders would be excited to see that the share price has had a great month, posting...
Artículo de análisis • Dec 25

Is TerrAscend (TSE:TSND) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis • Aug 13

TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Rentabilidad de los accionistas

TSNDCA PharmaceuticalsMercado CA
7D3.3%2.1%-0.1%
1Y-18.3%1.7%23.9%

Rentabilidad vs. Industria: Los resultados de TSND fueron inferiores a los de la industria Canadian Pharmaceuticals, que obtuvo un rendimiento del 1.7% el año pasado.

Rentabilidad vs. Mercado: TSND obtuvo unos resultados inferiores a los del mercado Canadian, que fueron del 23.9% el año pasado.

Volatilidad de los precios

Is TSND's price volatile compared to industry and market?
TSND volatility
TSND Average Weekly Movement10.1%
Pharmaceuticals Industry Average Movement8.3%
Market Average Movement9.4%
10% most volatile stocks in CA Market16.3%
10% least volatile stocks in CA Market3.7%

Precio estable de las acciones: TSND no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado Canadian.

Volatilidad a lo largo del tiempo: La volatilidad semanal de TSND ha disminuido de 22% a 10% en el último año.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
2017933Ziad Ghanemwww.terrascend.com

TerrAscend Corp. cultiva, produce y vende productos de cannabis en Canadá y Estados Unidos. La empresa fabrica vaporizables, concentrados, tópicos, flores, tinturas y comestibles. Ofrece sus productos bajo las marcas Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies y Lemonnade.

Resumen de fundamentos de TerrAscend Corp.

¿Cómo se comparan los beneficios e ingresos de TerrAscend con su capitalización de mercado?
Estadísticas fundamentales de TSND
Capitalización bursátilCA$350.31m
Beneficios(TTM)-CA$43.89m
Ingresos (TTM)CA$364.43m
0.8x
Ratio precio-ventas (PS)
-6.6x
Ratio precio-beneficio (PE)

¿Está TSND sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de TSND
IngresosUS$263.91m
Coste de los ingresosUS$124.65m
Beneficio brutoUS$139.26m
Otros gastosUS$171.05m
Beneficios-US$31.78m

Últimos beneficios comunicados

Jun 30, 2026

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.10
Margen bruto52.77%
Margen de beneficio neto-12.04%
Ratio deuda/patrimonio254.1%

¿Cómo se ha desempeñado TSND a largo plazo?

Ver rendimiento histórico y comparativa

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/09 19:16
Precio de las acciones al final del día2026/09/09 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

TerrAscend Corp. está cubierta por 9 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Frederico Yokota Choucair GomesATB Cormark
Matt BottomleyCanaccord Genuity
Shaan MirCanaccord Genuity

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros